Cadrenal Therapeutics, Inc. — 8-K Filings
46 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Cadrenal Therapeutics, Inc. (CVKD), sorted by most recent first. Each row links to the full filing on EdgarLookup. Cadrenal Therapeutics, Inc. has filed 46 8-K documents with the SEC since 2022. To view all SEC filings by Cadrenal Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-26-026646 | Mar 12, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-019606 | Feb 24, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-25-125433 | Dec 23, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-121932 | Dec 16, 2025 | Dec 15, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-120360 | Dec 11, 2025 | Dec 10, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-116307 | Dec 1, 2025 | Nov 24, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-112123 | Nov 18, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-107949 | Nov 10, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-091109 | Sep 24, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-087461 | Sep 15, 2025 | Sep 12, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-074355 | Aug 11, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-071764 | Aug 5, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-065710 | Jul 18, 2025 | Jul 15, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-041049 | May 8, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-032732 | Apr 17, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-023762 | Mar 13, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-019747 | Mar 4, 2025 | Mar 3, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-011315 | Feb 7, 2025 | Feb 4, 2025 |
| 8-K | CURRENT REPORT | 0001213900-24-095195 | Nov 7, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-094155 | Nov 4, 2024 | Nov 1, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-090153 | Oct 24, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-081799 | Sep 25, 2024 | — |
| 8-K | FORM 8-K | 0001213900-24-076144 | Sep 5, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-070883 | Aug 20, 2024 | Aug 19, 2024 |
| 8-K | FORM 8-K | 0001213900-24-069941 | Aug 16, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-066613 | Aug 8, 2024 | Aug 7, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-065400 | Aug 6, 2024 | — |
| 8-K | CURRENT REPORT | 0001013762-24-003209 | Jul 31, 2024 | Jul 29, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-040955 | May 9, 2024 | May 8, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-031371 | Apr 9, 2024 | Apr 9, 2023 |
| 8-K | CURRENT REPORT | 0001213900-24-021512 | Mar 12, 2024 | Mar 11, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-021251 | Mar 11, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-020181 | Mar 5, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-012649 | Feb 12, 2024 | Feb 6, 2024 |
| 8-K | CURRENT REPORT | 0001213900-23-084969 | Nov 9, 2023 | — |
| 8-K | FORM 8-K | 0001013762-23-005859 | Oct 23, 2023 | Oct 20, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-075392 | Sep 8, 2023 | Sep 6, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-068695 | Aug 18, 2023 | Aug 17, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-068206 | Aug 16, 2023 | Aug 15, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-065305 | Aug 10, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-059049 | Jul 24, 2023 | Jul 23, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-057132 | Jul 14, 2023 | Jul 12, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-043184 | May 26, 2023 | May 25, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-037928 | May 10, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-022987 | Mar 27, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-005108 | Jan 25, 2023 | Jan 19, 2023 |